COVID-19 in tralokinumab-treated patients with moderate-to-severe atopic dermatitis: case series from the ECZTEND long-term extension trial

Blauvelt, A.; Pink, A.; Worm, M.; Langley, R.; Costanzo, A.; Gjerum, L.; Jorgensen, E.; Corriveau, J.; Guttman-Yassky, E.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

COVID-19 in tralokinumab-treated patients with moderate-to-severe atopic dermatitis: case series from the ECZTEND long-term extension trial

Blauvelt, A.; Pink, A.; Worm, M.; Langley, R.; Costanzo, A.; Gjerum, L.; Jorgensen, E.; Corriveau, J.; Guttman-Yassky, E..

British Journal of Dermatology ; 185(3):E109-E110, 2021.

Article in English | Web of Science | ID: covidwho-1396020

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Randomized controlled trials Topics: Long Covid Language: English Journal: British Journal of Dermatology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

Collection: Databases of international organizations Database: Web of Science Type of study: Randomized controlled trials Topics: Long Covid Language: English Journal: British Journal of Dermatology Year: 2021 Document Type: Article